Back to search

Revolo Biotherapeutics Limited

07828414

active
ltd
england wales
Companies House
Health Score
68 / 100

Some Concerns

30/30
Filing
0/30
Financial
38/40
Risk
  • Negative net worth (-10)
  • Going concern doubt noted in accounts (-10)
  • 1 outstanding charge (-2)

Details

C/O Windsor House Station Court, Station Road, Great Shelford, Cambridge, CB22 5NE
Incorporated 31/10/2011

Previously known as

Immune Regulation Limited · until 27/02/2021
Peptinnovate Limited · until 03/10/2018
Newincco 1132 Limited · until 18/11/2011

Compliance

Last accounts

31/03/2025

total exemption full

Next accounts due

31/12/2026

On track

Confirmation statement

Last: 31/10/2025

Due 14/11/2026

On track

Industry

72110
Research and experimental development on biotechnology

Officers

Bcs Cosec Limited

secretary · Since 21/11/2014

Also on 160 other boards

Mr Isaac S. Cheng

director · Since 17/09/2020

BIOTECH INVESTOR

AMERICAN · UNITED STATES · Age 51

Also on 4 other boards

Mr Peter Scott Greenleaf

director · Since 23/11/2020

CEO

AMERICAN · UNITED STATES · Age 56

Also on 2 other boards

Mr Michael Albisser

director · Since 25/01/2021

COMPANY DIRECTOR

SWISS · SWITZERLAND · Age 57

Also on 1 other board

Mr Glen Thomas Giovannetti

director · Since 01/07/2021

CERTIFIED PUBLIC ACCOUNTANT (RETIRED)

AMERICAN · UNITED STATES · Age 63

Ms Marla Susan Persky

director · Since 01/07/2021

ATTORNEY (RETIRED), BOARD MEMBER

AMERICAN · UNITED STATES · Age 70

Dr Babatunde Otulana

director · Since 01/08/2021

PHYSICIAN

AMERICAN · UNITED STATES · Age 70

Jones Woodrow Bryan

director · Since 03/01/2024

PRESIDENT AND CEO

AMERICAN · UNITED STATES · Age 62

Also on 1 other board

Mr Gunnar Jan Walstam

director · Since 15/07/2025

ENTREPRENEUR

SWISS,SWEDISH · SWITZERLAND · Age 71

Mr Marek Stefan Gumienny

director · Since 12/12/2025

BRITISH · UNITED KINGDOM · Age 67

Bcs Cosec Limited

corporate secretary · Since 21/11/2014

Reg: 04018490

Also on 160 other boards

Isaac S. Cheng

director · Since 17/09/2020

American · United States · Age 51

Peter Scott Greenleaf

director · Since 23/11/2020

American · United States · Age 56

Michael Albisser

director · Since 25/01/2021

Swiss · Switzerland · Age 57

Marla Susan Persky

director · Since 01/07/2021

American · United States · Age 70

Glen Thomas Giovannetti

director · Since 01/07/2021

American · United States · Age 63

Babatunde Otulana

director · Since 01/08/2021

American · United States · Age 70

Jones Woodrow Bryan

director · Since 03/01/2024

American · United States · Age 62

Gunnar Jan Walstam

director · Since 15/07/2025

Swiss,Swedish · Switzerland · Age 71

Former

Olswang Directors 1 Limited

corporate director · Resigned 17/11/2011

Christopher Alan Mackie

director · Resigned 17/11/2011

Olswang Directors 2 Limited

corporate director · Resigned 17/11/2011

Olswang Cosec Limited

corporate secretary · Resigned 21/11/2014

Erik Van Kaathoven

director · Resigned 28/07/2015

Andrew Phillip Lightfoot

director · Resigned 11/02/2017

Thierry Plouvier

director · Resigned 31/08/2017

Anthony Francis Martin

director · Resigned 31/07/2018

David Colin Beadle

director · Resigned 24/10/2019

Ben Major George Cons

director · Resigned 14/02/2020

Richard Nagle

director · Resigned 03/07/2020

Michael Albisser

director · Resigned 17/09/2020

Christopher Smith

director · Resigned 17/09/2020

Gunnar Walstam

director · Resigned 17/09/2020

Clive Page

director · Resigned 23/10/2020

Dominik Escher

director · Resigned 27/11/2020

Jonathan Michael Norman Rigby

director · Resigned 03/01/2024

David Peabody Southwell

director · Resigned 19/05/2025

Charges1 outstanding

Charge
outstanding

BRIDGE HAMPTON INVESTMENTS AG

Created 04/03/2025Registered 05/03/2025

Change History

statusactive
2026-07-12

Active

typeltd
2026-07-12

Private Limited Company

address line1C/O Windsor House Station Court, Station Road
2026-07-12

C/O WINDSOR HOUSE STATION COURT, STATION ROAD

post townCambridge
2026-07-12

CAMBRIDGE

CompanyRankvs 2884+ SIC 72110 peers
13

Financial strength1th percentile among SIC peers · 0/25
Employees22th percentile among SIC peers · 3/15
LiquidityNo balance sheet data · 0/20
Longevity15 years trading (max 15) · 15/15
Filing complianceAll filings up to date · 15/15
Going concern doubt -10Outstanding charges -10
Show leaderboard
How is this score calculated?
Financial strength0/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees3/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity0/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity15/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Risk deductions

Going concern doubt: -10 pts

Outstanding charges: -10 pts

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Going Concern Doubt

assume that the Company will continue to receive support from its shareholders. However, there are material uncertainties that may cast significant doubt on the Company’s ability to continue as a going concern. These uncertainties include: ∙ the Company’s ability to generate revenue in the near term; ∙ the successful completion of interim and longer-term fundraising; ∙ the timing and cost of the c

Key FinancialsYear ending 31/03/2026

Net Worth

-£11.0M

Balance sheet strength

Cash

Cash in the bank

Net Current Assets

Working capital

Current Assets

Current Liabilities

Profit After Tax

-£5.8M

0avg. employees

Balance Sheet

Total assets£2.9M
Prepared with Caseware UK (AP4) 2025.0.111